Development Updates. Throughout the Term, Genentech shall provide to ACI periodic updates on the plan for development of Licensed Products containing ACI Antibody(ies) or Program Antibody(ies) under this Agreement on at least a [*****] basis. Such updates to include a summary of any significant progress or advances along with a general description of Genentech’s then-current plan of development. It is understood and agreed that the development plan summaries provided under this Section 3.1.4 are non-binding and provided to ACI for informational purposes only.
Appears in 4 contracts
Samples: Research Collaboration and License Agreement (AC Immune SA), Research Collaboration and License Agreement (AC Immune SA), Research Collaboration and License Agreement (AC Immune SA)
